An effective anti-tumor immune response requires antigen presentation, in which MHC class 1 molecules, such as HLA-A, HLA-B, and HLA-C, present antigenic peptides from tumor cells or DC to CD8 T cells. The gene discussed is HLA-B; the disease is neoplasm.